Login/Sign Up
₹2304
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Celbopag 50 Tablet is a prescription oral medicine used to treat low blood platelet counts (thrombocytopenia) in patients with chronic immune thrombocytopenia (ITP) when other treatments have not worked well. It is also prescribed to treat severe aplastic anemia and low platelets caused by chronic hepatitis C infection.
To get the best results, you must take Celbopag 50 Tablet consistently every day exactly as directed by your doctor. You should take Celbopag 50 Tablet on an empty stomach, either at least 1 hour before or 2 hours after eating. Avoid consuming dairy products, calcium-fortified juices, or mineral supplements close to your dose, as they can stop your body from absorbing the medicine.
While taking Celbopag 50 Tablet, you may experience mild side effects like nausea, diarrhea, or muscle aches. However, you must contact your doctor immediately if you notice signs of liver damage, such as yellowing of your eyes or skin, dark urine, or unusual tiredness.
Before starting Celbopag 50 Tablet, tell your doctor if you have a history of liver disease, blood clots, or cataracts. Do not take this if you are allergic to any of its ingredients. A long-term blood condition can feel stressful, especially when frequent blood tests and bleeding risks affect daily life. Celbopag 50 Tablet is prescribed to help improve platelet counts and support your ongoing treatment plan.
Celbopag 50 Tablet can interact with certain medications, including antacids, cholesterol-lowering drugs, and mineral supplements, which can make it less effective. If you are pregnant, planning to become pregnant, breastfeeding, or are an older adult, consult your doctor or pharmacist to discuss whether Celbopag 50 Tablet is safe for you. Celbopag 50 Tablet may also be prescribed for children aged 1 year and older with chronic immune thrombocytopenia (ITP) when other treatments have not worked well. The dose for children is carefully determined by a specialist.
Celbopag 50 Tablet is used in the treatment of low platelet count (thrombocytopenia) in various blood-related disorders. The detailed uses of Celbopag 50 Tablet are as follows:
Caution
Limit alcohol intake, along with Celbopag 50 Tablet, to attain the maximum efficacy of Celbopag 50 Tablet and rule out any possibility of worsening of side effects.
Unsafe
Celbopag 50 Tablet is not recommended in pregnancy. It may affect and harm the developing baby. Please consult your doctor if you are pregnant or planning to conceive.
Caution
It is not known if Celbopag 50 Tablet is excreted into the breast milk. Please consult your doctor for more information before taking Celbopag 50 Tablet if you are a nursing mother.
Caution
Celbopag 50 Tablet may cause dizziness and tiredness affecting your ability to concentrate and drive. Hence, it is recommended not to drive or operate machinery until you are mentally alert.
Caution
Let your doctor know if you have any history of liver diseases before taking Celbopag 50 Tablet. Celbopag 50 Tablet may cause an increase in liver enzymes. Your doctor may start the treatment with a lower dose of Celbopag 50 Tablet.
Consult your doctor
Celbopag 50 Tablet should be used with caution in cases of renal impairment. It is advised to seek doctor advice before starting Celbopag 50 Tablet if you have any kidney problems.
Caution
Celbopag 50 Tablet is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.
Consult your doctor
Please inform your doctor if you have a history of heart disease before using Celbopag 50 Tablet. Your doctor will prescribe it only if the benefits outweigh the risks.
Safe if prescribed
Celbopag 50 Tablet is safe for use in elderly patients if prescribed by the physician.
Have a query?
The time required for Celbopag 50 Tablet to start to work: Celbopag 50 Tablet ideally shows its action within 2 to 6 hours after administration. The time for which the effects of Celbopag 50 Tablet last: The duration of action for Celbopag 50 Tablet is clinically unknown.
Login/Sign Up
Login/Sign Up
Disclaimer
